Title: Transcending Biomarker Data Chaos: How Integrating Disparate PK, Clinical & Exploratory Data Enables Deep Translational Insights
Duration: 30 minutes
You will see how teams unlock translational intelligence:
- Navigate vast exploratory data – identify trends and data points of interest
- Surface insights – analyze biomarker trends in collaborative dashboards across subject IDs, time points, response status, and treatment groups
- Access data rapidly – point and click navigation to underlying data files to interrogate the raw data behind the summary values
- Interrogate cross assay – map to a common data dictionary to enable rapid interrogation of trends across assay modalities: within and across studies
Abstract of the Webinar
Clinical trials today frequently generate complex exploratory biomarker data, supported by a distributed network of specialty labs, which results in siloed data formats and inconsistent annotations across labs.
This “biomarker data chaos” is a persistent frustration – since any analysis requires intense manual curation and preparation of data.
Join us for this 30-minute webinar, where Tobi Guennel will demonstrate how integrating exploratory biomarker, PK, and clinical data silos in a translational hub enables teams to interrogate trends and identify insights as data is generated on-study.
During the presentation, our team will highlight how data integration technology, consisting of sophisticated connectors and scalable data workflows, enables the rapid assimilation and synthesis of historically disparate data.
Who should attend:
- Translational Research Teams
- Biomarker Strategy Teams
- Clinical Development Teams
- Office of the CIO/CTO
- Data Management teams
About the Speaker:Tobi Guennel, Ph.D. |
As the Chief Architect of our Data Integration and Informatics Platform, Tobi Guennel supports life science companies in their quest to improve patient care and outcomes. QuartzBio, part of Precision for Medicine, is providing a technology-enabled next-generation data science solution to accelerate drug development. |
